DE69519385D1 - Chinazolinon-arzneimittel sowie deren verwendung - Google Patents

Chinazolinon-arzneimittel sowie deren verwendung

Info

Publication number
DE69519385D1
DE69519385D1 DE69519385T DE69519385T DE69519385D1 DE 69519385 D1 DE69519385 D1 DE 69519385D1 DE 69519385 T DE69519385 T DE 69519385T DE 69519385 T DE69519385 T DE 69519385T DE 69519385 D1 DE69519385 D1 DE 69519385D1
Authority
DE
Germany
Prior art keywords
group
hydrogen
chinazolinone
medicines
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69519385T
Other languages
English (en)
Other versions
DE69519385T2 (de
Inventor
Arnon Nagler
Shimon Slavin
Israel Vlodavsky
Mark Pines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hadasit Medical Research Services and Development Co
Agricultural Research Organization of Israel Ministry of Agriculture
Original Assignee
Hadasit Medical Research Services and Development Co
Agricultural Research Organization of Israel Ministry of Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Medical Research Services and Development Co, Agricultural Research Organization of Israel Ministry of Agriculture filed Critical Hadasit Medical Research Services and Development Co
Publication of DE69519385D1 publication Critical patent/DE69519385D1/de
Application granted granted Critical
Publication of DE69519385T2 publication Critical patent/DE69519385T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
DE69519385T 1994-08-31 1995-08-29 Chinazolinon-arzneimittel sowie deren verwendung Expired - Fee Related DE69519385T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11083194A IL110831A (en) 1994-08-31 1994-08-31 Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
PCT/US1995/011186 WO1996006616A1 (en) 1994-08-31 1995-08-29 Quinazolinone pharmaceuticals and use thereof

Publications (2)

Publication Number Publication Date
DE69519385D1 true DE69519385D1 (de) 2000-12-14
DE69519385T2 DE69519385T2 (de) 2001-03-15

Family

ID=11066514

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69519385T Expired - Fee Related DE69519385T2 (de) 1994-08-31 1995-08-29 Chinazolinon-arzneimittel sowie deren verwendung

Country Status (8)

Country Link
EP (1) EP0787000B1 (de)
JP (1) JPH10513149A (de)
CN (1) CN1108797C (de)
AT (1) ATE197401T1 (de)
AU (1) AU692307B2 (de)
DE (1) DE69519385T2 (de)
IL (1) IL110831A (de)
WO (1) WO1996006616A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
EP0936910B1 (de) * 1996-08-30 2002-07-24 Agricultural Research Organization, Ministry Of Agriculture, State Of Israel Intracoronarer stent der quinazolinone derivate enthält
US6028075A (en) 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
US6211188B1 (en) * 1997-02-11 2001-04-03 Hadasit Medical Research Services And Development Company Ltd Treatment of skin disorders
US6562829B1 (en) 1997-05-23 2003-05-13 Hadasit Medical Research Services & Development Co., Ltd. Treatment of hepatic cirrhosis
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
WO2000009070A2 (en) * 1998-08-13 2000-02-24 Hadasit Medical Research Services And Development Company Ltd. Inhibition of pathogenic processes related to tissue trauma
US7064114B2 (en) 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
WO2000056338A1 (en) * 1999-03-19 2000-09-28 Parker Hughes Institute Quinazoline formulations and therapeutic use thereof
DE69934336T2 (de) * 1999-09-09 2007-07-05 Hadasit Medical Research Services & Development Co. Ltd. Verwendung von halofuginone zur behandlung von urethralstriktur
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
WO2003043995A1 (en) 2001-11-20 2003-05-30 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
MX2009013815A (es) 2007-06-22 2010-03-01 Arqule Inc Compuestos de quinazolinona y metodos de uso para los mismos.
CN114469956B (zh) * 2022-01-29 2023-07-18 中国科学技术大学 常山酮在治疗和预防动脉粥样硬化性疾病的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26833A (en) * 1860-01-17 Improvement in plows
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
DE3703789A1 (de) * 1987-02-07 1988-08-18 Hoechst Ag Coccidiozide mittel
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
JPH10513149A (ja) 1998-12-15
EP0787000B1 (de) 2000-11-08
WO1996006616A1 (en) 1996-03-07
EP0787000A1 (de) 1997-08-06
AU692307B2 (en) 1998-06-04
CN1108797C (zh) 2003-05-21
ATE197401T1 (de) 2000-11-11
IL110831A (en) 1998-12-27
CN1163566A (zh) 1997-10-29
IL110831A0 (en) 1994-11-11
DE69519385T2 (de) 2001-03-15
EP0787000A4 (de) 1997-11-12
AU3626895A (en) 1996-03-22

Similar Documents

Publication Publication Date Title
CO5031285A1 (es) Triarilimidazoles
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
MX9707453A (es) Derivados de quinazolina.
TR199800697T2 (xx) Farmas�tik olarak aktif kinazolin bile�imleri.
CA2280850A1 (en) Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
UA35557C2 (uk) Похідні 1,2,4-оксадіазолілфеноксіалкілізоксазолу, що мають противірусну активність та фармацевтична композиція на їх основі
ATE156119T1 (de) 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
SE9504662D0 (sv) New compounds
AU6846996A (en) Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies
ATE192040T1 (de) Wirkstoff gegen arteriosklerose
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
TR200001941T1 (tr) TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri.
DK0900082T3 (da) Anvendelse af pyridyl- og pyrimidyl-piperaziner til fremstilling af et lægemiddel til behandling af rusgiftbetingede lidelser
ATE240329T1 (de) Zytotoxische pyrido(2,3,4-kl)acridinderivate, ihre herstellung und therapeutische verwendung
CA2198875A1 (en) Quinazolinone pharmaceuticals and use thereof
SE9603284D0 (sv) New compounds
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater
TH19066A (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด
PT1068199E (pt) N-ariloxietil-indoli-alquilaminas para o tratamento da depressao
TH19066EX (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด
HUP9904002A2 (hu) Hasnyálmirigy-gyulladás kezelésére vagy megelőzésére alkalmas, hatóanyagként diarilalkánszármazékokat tartalmazó gyógyászati készítmények
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee